Free Trial

MoonLake Immunotherapeutics (MLTX) Short Interest Ratio & Short Volume

-1.09 (-2.74%)
(As of 05/20/2024 ET)

MoonLake Immunotherapeutics Short Interest Data

Current Short Interest
Previous Short Interest
Change Vs. Previous Month
Dollar Volume Sold Short
$283.51 million
Short Interest Ratio
15.0 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling MoonLake Immunotherapeutics ?

Sign up to receive the latest short interest report for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

MLTX Short Interest Over Time

MLTX Days to Cover Over Time

MLTX Percentage of Float Shorted Over Time

MoonLake Immunotherapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20246,930,000 shares $283.51 million -4.6%14.0%15 $40.91
4/15/20247,260,000 shares $316.83 million -5.1%15.4%15.4 $43.64
3/31/20247,650,000 shares $384.26 million +9.3%16.2%15.9 $50.23
3/15/20247,000,000 shares $330.75 million +0.9%14.8%14.8 $47.25
2/29/20246,940,000 shares $334.79 million +5.0%14.7%14.5 $48.24
2/15/20246,610,000 shares $396.80 million -0.9%14.1%13.3 $60.03
1/31/20246,670,000 shares $372.72 million -3.2%14.5%12.2 $55.88
1/15/20246,890,000 shares $401.69 million -0.3%15.0%10.4 $58.30
12/31/20236,910,000 shares $417.29 million -8.0%15.0%9.6 $60.39
12/15/20237,510,000 shares $455.48 million -4.1%16.3%10.4 $60.65
11/30/20237,830,000 shares $343.82 million +7.0%17.7%10.9 $43.91
11/15/20237,320,000 shares $287.38 million +10.2%16.6%10.6 $39.26
10/31/20236,640,000 shares $344.02 million -6.4%16.7%10.4 $51.81
10/15/20237,090,000 shares $387.61 million +3.5%19.7%13.8 $54.67
9/30/20236,850,000 shares $390.45 million +4.1%19.0%14.1 $57.00
9/15/20236,580,000 shares $369.93 million -1.2%15.6%8.7 $56.22
8/31/20236,660,000 shares $383.42 million -10.1%16.8%9.1 $57.57
8/15/20237,410,000 shares $417.03 million +10.6%18.7%10.1 $56.28
7/31/20236,700,000 shares $407.43 million +1.8%16.8%9.2 $60.81
7/15/20236,580,000 shares $357.10 million +6.8%15.2%8.9 $54.27
6/30/20236,160,000 shares $314.16 million +33.9%17.2%8.8 $51.00
6/15/20234,600,000 shares $125.12 million +12.5%13.9%8.5 $27.20
5/31/20234,090,000 shares $111.29 million -5.3%12.8%10.5 $27.21
5/15/20234,320,000 shares $115.60 million +30.1%13.6%12.2 $26.76
4/30/20233,320,000 shares $70.72 million +78.5%12.0%11 $21.30
4/15/20231,860,000 shares $35.41 million +0.5%6.7%6.9 $19.04
3/31/20231,850,000 shares $39.57 million +119.4%6.5%9.1 $21.39
3/15/2023843,300 shares $17.13 million -4.5%2.7%4.7 $20.31
2/28/2023883,400 shares $16.95 million +44.4%2.8%6.9 $19.19
2/15/2023611,800 shares $10.27 million -0.1%1.9%6 $16.79
1/31/2023612,600 shares $7.32 million -0.8%1.9%7.6 $11.95
1/15/2023617,300 shares $7.34 million +0.7%1.9%8.8 $11.89
12/30/2022612,800 shares $6.43 million -14.7%1.9%10.1 $10.50
12/15/2022718,100 shares $6.75 million -15.1%2.3%12.5 $9.40
11/30/2022845,400 shares $8.39 million +38.1%2.7%18.9 $9.93
11/15/2022612,200 shares $5.48 million +0.8%2.0%14.5 $8.95
10/31/2022607,100 shares $5.00 million +1.0%2.0%13.3 $8.24
10/15/2022601,400 shares $5.29 million +0.7%2.0%11 $8.80
9/30/2022597,000 shares $4.63 million +2.5%2.0%10.3 $7.76
9/15/2022582,300 shares $4.48 million +1.5%2.0%11.7 $7.69
Does this make you sick? (Ad)

The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.

Get your Free Wealth Protection Kit
8/31/2022573,900 shares $4.63 million -3.4%1.9%9.7 $8.06
8/15/2022594,100 shares $4.24 million -7.2%1.8%6.8 $7.13
7/31/2022640,100 shares $4.03 million +6.5%1.9%7.7 $6.30
7/15/2022601,300 shares $3.53 million No Change1.8%6.6 $5.87

MLTX Short Interest - Frequently Asked Questions

What is MoonLake Immunotherapeutics' current short interest?

Short interest is the volume of MoonLake Immunotherapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 6,930,000 shares of MLTX short. 14.00% of MoonLake Immunotherapeutics' shares are currently sold short. Learn More on MoonLake Immunotherapeutics' current short interest.

What is a good short interest ratio for MoonLake Immunotherapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MLTX shares currently have a short interest ratio of 15.0. Learn More on MoonLake Immunotherapeutics's short interest ratio.

Which institutional investors are shorting MoonLake Immunotherapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of MoonLake Immunotherapeutics: Ikarian Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for MoonLake Immunotherapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.00% of MoonLake Immunotherapeutics' floating shares are currently sold short.

Is MoonLake Immunotherapeutics' short interest increasing or decreasing?

MoonLake Immunotherapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 6,930,000 shares, a decline of 4.5% from the previous total of 7,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is MoonLake Immunotherapeutics' float size?

MoonLake Immunotherapeutics currently has issued a total of 63,890,000 shares. Some of MoonLake Immunotherapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MoonLake Immunotherapeutics currently has a public float of 49,500,000 shares.

How does MoonLake Immunotherapeutics' short interest compare to its competitors?

14.00% of MoonLake Immunotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MoonLake Immunotherapeutics: Bausch Health Companies Inc. (5.73%), Merus (5.76%), Maravai LifeSciences Holdings, Inc. (6.66%), Janux Therapeutics, Inc. (9.55%), Rhythm Pharmaceuticals, Inc. (17.37%), Dyne Therapeutics, Inc. (18.91%), ACADIA Pharmaceuticals Inc. (7.28%), Amicus Therapeutics, Inc. (9.71%), Avidity Biosciences, Inc. (11.91%), MorphoSys AG (0.83%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short MoonLake Immunotherapeutics stock?

Short selling MLTX is an investing strategy that aims to generate trading profit from MoonLake Immunotherapeutics as its price is falling. MLTX shares are trading down $1.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against MoonLake Immunotherapeutics?

A short squeeze for MoonLake Immunotherapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MLTX, which in turn drives the price of the stock up even further.

How often is MoonLake Immunotherapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MLTX, twice per month. The most recent reporting period available is April, 30 2024.

More Short Interest Resources from MarketBeat

This page (NASDAQ:MLTX) was last updated on 5/21/2024 by Staff

From Our Partners